Who has invested in Reata Pharmaceuticals?

Novo A/S, CPMG are named among the investors backing Reata Pharmaceuticals.

Reata Pharmaceuticals Funding: $180M Raised, IPO (2016)

Reata Pharmaceuticals funding overview

Reata Pharmaceuticals is based in Irving. Reata Pharmaceuticals has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in January 2016. The round record for Reata Pharmaceuticals runs through 2016; nothing later has been disclosed. Investors on record include Novo A/S, CPMG. 2 distinct backers are named across the disclosed rounds.

Reata Pharmaceuticals at a glance

Total raised: $180M
Latest round: IPO
Latest round date: January 2016
Headquarters: Irving
Notable investors: Novo A/S, CPMG

Frequently asked about Reata Pharmaceuticals funding

How much has Reata Pharmaceuticals raised?: Reata Pharmaceuticals has raised $180M in total disclosed funding across the rounds on record.
Who has invested in Reata Pharmaceuticals?: Novo A/S, CPMG are named among the investors backing Reata Pharmaceuticals.
What was the latest Reata Pharmaceuticals funding round?: The most recent disclosed round is an IPO, announced in January 2016.
Where is Reata Pharmaceuticals based?: Reata Pharmaceuticals is based in Irving.
When did Reata Pharmaceuticals last raise?: The last disclosed Reata Pharmaceuticals round closed in January 2016 at IPO.

Reata Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Irving below to benchmark round size and investor mix.

Reata Pharmaceuticals Funding: $180M Raised, IPO (2016)

Reata Pharmaceuticals funding overview

Reata Pharmaceuticals at a glance

Frequently asked about Reata Pharmaceuticals funding

Companies related to Reata Pharmaceuticals (15)

Browse related funding lists (3)